Raav with chemically modified capsid
US-2019388557-A1 · Dec 26, 2019 · US
US10086095B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10086095-B2 |
| Application number | US-201314434435-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 9, 2013 |
| Priority date | Oct 9, 2012 |
| Publication date | Oct 2, 2018 |
| Grant date | Oct 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A rod-shaped plant virus having an interior surface and an exterior surface, and at least one imaging agent that is linked to the interior and/or exterior surface is described. The rod-shaped viruses can be combined into larger spherical nanoparticles. A rod-shaped plant virus or spherical nanoparticles including an imaging agent can be used in a method of generating an image of a tissue region of a subject such as a tumor or atherosclerotic tissue by administering the virus particle to the subject and generating an image of the tissue region of the subject to which the virus particle has been distributed.
Opening claim text (preview).
What is claimed is: 1. A rod-shaped plant virus having an interior surface and an exterior surface, and at least one imaging agent that is linked to the interior and/or exterior surface of the virus, wherein the virus has a longitudinal relaxivity of greater than about 10 mM −1 S −1 per linked imaging agent at 60 mHz. 2. The rod-shaped plant virus of claim 1 , wherein the imaging agent is a magnetic resonance imaging agent. 3. The rod-shaped plant virus of claim 1 , wherein the imaging agent is a chelated lanthanide. 4. The rod-shaped plant virus of claim 3 , wherein the lanthanide is gadolinium. 5. The rod-shaped plant virus of claim 1 , wherein the imaging agent is linked to the interior and the exterior of the virus. 6. The rod-shaped plant virus of claim 1 , wherein a first imaging agent is linked to the interior of the virus and a second, different imaging agent is linked to the exterior of the virus. 7. The rod-shaped plant virus of claim 1 , wherein a targeting moiety is linked to the exterior surface of the virus. 8. The rod-shaped plant virus of claim 1 , wherein the rod-shaped virus is PEGylated. 9. The rod-shaped plant virus of claim 1 , wherein at least about 3000 imaging agent molecules are linked to the virus particle. 10. The rod-shaped plant virus of claim 1 , wherein the plant virus belongs to the Virgaviridae family. 11. The rod-shaped plant virus of claim 1 , wherein the virus is a tobacco mosaic virus. 12. The rod-shaped plant virus of claim 1 , wherein the virus has a longitudinal relaxivity of greater than about 10 mM −1 S −1 per particle when measured at 60 mHz at a physiological pH. 13. A method of generating an image of a tissue region of a subject, by administering to the subject a diagnostically effective amount of a rod-shaped plant virus particle having an imaging agent linked to an interior and/or exterior surface of the virus particle, and generating an image of the tissue region of the subject to which the rod-shaped plant virus particle has been distributed. 14. The method of claim 13 , wherein the rod-shaped plant virus is a tobacco mosaic virus. 15. The method of claim 13 , wherein the method of generating an image is magnetic resonance imaging, and the imaging agent is a chelated lanthanide. 16. The method of claim 13 , wherein the rod-shaped plant virus particle is administered together with a pharmaceutically acceptable carrier. 17. The method of claim 13 , wherein the tissue region includes a tumor. 18. The method of claim 13 , wherein the tissue region includes a blood vessel.
Nanotubes, nanorods or nanowires · CPC title
Uses of virus other than therapeutic or vaccine, e.g. disinfectant · CPC title
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.